Investors

Insider Transactions

Date Sorted Ascending Name Title Type Shares Traded Price Range
Feb 14, 2012 stahl neil Officer Disposition (Non Open Market) 28,918 111.01
Feb 15, 2012 gilman alfred g Director Sell 26,734 109.56
Feb 15, 2012 mccorkle douglas s Officer Sell 9,097 111.08
Feb 15, 2012 schleifer leonard s Officer Disposition (Non Open Market) 6,257 111.01
Feb 15, 2012 stahl neil Officer Sell 21,082 107.79 - 108.09
Feb 15, 2012 yancopoulos george Officer Option Execute 133,332 8.50
Feb 15, 2012 yancopoulos george Officer Disposition (Non Open Market) 67,017 109.29
Feb 16, 2012 mccorkle douglas s Officer Sell 5,353 107.50
Feb 21, 2012 powchik peter Officer Option Execute 109,866 15.64 - 21.92
Feb 21, 2012 powchik peter Officer Automatic Sell 60,612 100.32
Feb 22, 2012 powchik peter Officer Automatic Sell 49,254 94.71 - 98.05
Feb 23, 2012 shooter eric m Director Sell 20,000 103.51 - 104.05
Feb 23, 2012 shooter eric m Director Acquisition (Non Open Market) 20,000 n/a
Mar 1, 2012 brown michael s Director Option Execute 20,000 15.80 - 19.69
Mar 1, 2012 brown michael s Director Automatic Sell 20,000 102.65 - 104.32
Mar 15, 2012 goldstein joseph l Director Option Execute 10,000 18.61
Mar 15, 2012 goldstein joseph l Director Automatic Sell 10,000 110.77 - 115.00
Mar 26, 2012 goldstein joseph l Director Option Execute 5,000 18.61
Mar 26, 2012 goldstein joseph l Director Automatic Sell 5,000 120.00
Mar 26, 2012 yancopoulos george Officer Automatic Sell 33,150 120.21 - 121.09
Showing 401-420 of 842 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)